The Trump administration’s new TrumpRx deal with Eli Lilly and Novo Nordisk will slash GLP-1 drug prices, including Ozempic, ...
Investor's Business Daily on MSN
Trump Slashes Weight-Loss Drug Prices By Up To 74% In Deal With Lilly, Novo
The Trump administration announced deals Thursday with Eli Lilly and Novo Nordisk to slash the prices of their weight-loss ...
Trump announced big discounts to popular weight loss drugs Wegovy and Zepbound (also available for Diabetes treatment under the brand names Ozempic and Mounjaro ...
Trump said his administration reached an agreement with Novo Nordisk and Eli Lilly to lower the cost of GLP-1 weight loss ...
Trump announced new deals with Eli Lilly and Novo Nordisk to lower GLP-1 costs for Medicare, Medicaid, and cash-paying patients.
The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...
Trump administration strikes deal with Novo Nordisk and Eli Lilly to slash weight-loss drug costs. Wegovy starting doses drop ...
Counterfeit GLP-1's are emerging as a deadly public health threat. In the wake of one woman’s tragic death, another reveals ...
President Trump will announce concessions from Eli Lilly and Novo Nordisk that would lower the price of some of the companies ...
The deal is expected to lower the price of some obesity drugs to $149 per month in certain cases, according to reports.
For the inaugural MedPage Today Culture Awards, the MedPage Today social media team recognized some of the biggest cultural ...
Denmark-based Novo Nordisk, which makes Ozempic, Rybelsus and Wegovy; and Indianapolis-based Eli Lilly, which makes Zepbound, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback